Related Experiment Video
Updated: May 22, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer
Y-H Nicole Tsang1, X-W Wu, J-S Lim
1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Abstract:
Emerging evidence demonstrates that RUNX3 is a tumor suppressor in breast cancer. Inactivation of RUNX3 in mice results in spontaneous mammary gland tumors, and decreased or silenced expression of RUNX3 is frequently found in breast cancer cell lines and human breast cancer samples. However, the underlying mechanism for initiating RUNX3 inactivation in breast cancer remains elusive. Here, we identify prolyl isomerase Pin1, which is often overexpressed in breast cancer, as a key regulator of RUNX3 inactivation. In human breast cancer cell lines and breast cancer samples, expression of Pin1 inversely correlates with the expression of RUNX3. In addition, Pin1 recognizes four phosphorylated Ser/Thr-Pro motifs in RUNX3 via its WW domain. Binding of Pin1 to RUNX3 suppresses the transcriptional activity of RUNX3. Furthermore, Pin1 reduces the cellular levels of RUNX3 in an isomerase activity-dependent manner by inducing the ubiquitination and proteasomal degradation of RUNX3. Knocking down Pin1 enhances the cellular levels and transcriptional activity of RUNX3 by inhibiting the ubiquitination and degradation of RUNX3. Our results identify Pin1 as a new regulator of RUNX3 inactivation in breast cancer.
Insights
Prolyl isomerase Pin1 inactivates the breast cancer tumor suppressor RUNX3 by promoting its degradation. Pin1 overexpression correlates with reduced RUNX3, highlighting Pin1 as a therapeutic target in breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- RUNX3 functions as a tumor suppressor in breast cancer.
- RUNX3 inactivation is frequently observed in breast cancer, but the mechanisms remain unclear.
Purpose of the Study:
- To identify regulators of RUNX3 inactivation in breast cancer.
- To elucidate the role of prolyl isomerase Pin1 in RUNX3 regulation.
Main Methods:
- Correlation analysis of Pin1 and RUNX3 expression in breast cancer samples.
- Biochemical assays to determine Pin1-RUNX3 interaction and RUNX3 degradation.
- In vitro and cell-based assays to assess RUNX3 transcriptional activity.
Main Results:
- Pin1 expression inversely correlates with RUNX3 expression in breast cancer.
- Pin1 binds to phosphorylated motifs in RUNX3, suppressing its activity.
- Pin1 induces RUNX3 ubiquitination and proteasomal degradation in an isomerase-dependent manner.
- Knockdown of Pin1 restores RUNX3 levels and activity.
Conclusions:
- Pin1 is a key regulator of RUNX3 inactivation in breast cancer.
- Pin1 promotes RUNX3 degradation, contributing to tumorigenesis.
- Pin1 represents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs

